# A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Source: https://onco.cc/trials/nct07636785/  
OnCo record `nct07636785` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of VMD-102 in hepatocellular carcinoma, uveal melanoma, renal cell carcinoma, non-small-cell lung cancer and colorectal cancer, run by VM Discovery, Inc., now recruiting.

## Summary

A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors is a phase 1/2 interventional study registered as NCT07636785 by VM Discovery, Inc., with 111 participants planned, started 2026-07-16 and due to reach its primary completion in 2031-05. Interventions recorded: VMD-102.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07636785
- Phase: 1/2
- Setting: A Phase 1 and 2 First-in-human, Open-label, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of VMD-102 in Participants With Hepatocellular Carcinoma and Other Advanced Solid Tumors
- Sponsor: VM Discovery, Inc.
- Enrolled: 111

## Sources

- ClinicalTrials.gov NCT07636785: https://clinicaltrials.gov/study/NCT07636785

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Hepatocellular carcinoma](https://onco.cc/cancers/hcc/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Renal cell carcinoma](https://onco.cc/cancers/rcc/), [Uveal melanoma](https://onco.cc/cancers/uveal-melanoma/)

---
JSON: https://onco.cc/api/v1/entities/nct07636785.json